Bill Mezzanotte

Executive Vice President, Head R&D, Chief Medical Officer / CSL

Bill Mezzanotte is a senior physician and enterprise leader with substantial development, medical affairs and commercialization experience.

He has been involved in introducing and delivering strategies that lead to successful product development and sustainable growth across multiple therapeutic areas including respiratory, cardiovascular, metabolic, gastrointestinal, immunology, hematology and neuroscience. He also has experience with large and small molecule compounds, plasma proteins and across all the phases of product development.

Lists and Charts

Knowledge Bank : Person Roles

2018

Executive Vice President, Head R&D, Chief Medical Officer

CSL

Year started and most recent title

Total Shareholder Return as at 05/02/26

Rank	Company	1 Yr	5 Yr
1435^th	Pro Medicus	-33.74%	34.36%
1436^th	Xref	-33.76%	-16.06%
1437^th	CSL	-33.96%	-6.46%
1438^th	Adneo	-34.04%	-44.34%
1439^th	Knosys	-34.18%	-31.42%

View Full List

1663 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Person Activity

NEW ROLE: Executive Vice President, Head R&D, Chief Medical Officer, CSL

24 Nov 2020

Related Information

Access to our data for Bill Mezzanotte is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Bill Mezzanotte is linked to 2 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.